Which questions would help the nurse to evaluate the effectiveness of antipsychotic medications for a client who has schizophrenia? Select all that apply.

Schizophrenia involves a dysregulation of dopaminergic pathways, leading to positive symptoms like hallucinations and negative symptoms such as avolition. Antipsychotic efficacy is measured by the clinical reduction of psychotic intensity and the restoration of functional capacity, allowing the individual to navigate social and physical environments safely. Rationale: A. Assessing access to community agencies evaluates the client's support system and social determinants of health. Although critical for long-term stability, it does not directly measure the physiological or therapeutic efficacy of the antipsychotic medication on the brain's neurochemistry or symptom profile. B. Quality of life is a subjective measure of well-being and life satisfaction. Although antipsychotics can improve overall functioning, this question is too broad to isolate the specific pharmacological impact on the core psychotic symptoms that the medication is designed to target. C. Commitment to a drug regimen measures adherence and motivation rather than the medication's actual effectiveness. A client may be highly compliant with their prescription even if the drug is failing to provide therapeutic relief from their auditory hallucinations or delusions. D. The primary goal of antipsychotics is the remission of positive symptoms. Asking if symptoms have disappeared is a direct way for the nurse to evaluate the potency of the current dosage and the drug's success in blocking dopamine receptors in the mesolimbic pathway. E. Many clients experience residual symptoms despite optimal pharmacotherapy. Evaluating the ability to maintain functioning despite persistent symptoms is a sophisticated measure of therapeutic success, indicating that the medication has reduced symptom severity enough to permit activities of daily living.